The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma

Nadeem Butt; Maryam Enani; Maryam Alshanqiti; Alaa Alkhotani; Taghreed Alsinani; Mohammed Matoog Karami; Motaz M Fadul; Majid Almansouri; Amber Hassan; Saleh Baeesa; Ahmed K Bamaga; Shadi Alkhayyat; Eyad Faizo; Maher Kurdi

doi:10.5114/fn.2023.131014

eISSN: 1509-572x
ISSN: 1641-4640

Folia Neuropathologica

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2023
vol. 61

Send email

Copy url:

Original paper

The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma

Nadeem Butt

¹

,

Maryam Enani

²

,

Maryam Alshanqiti

³

,

Alaa Alkhotani

⁴

,

Taghreed Alsinani

⁵

,

Mohammed Matoog Karami

⁶

,

Motaz M Fadul

¹

,

Majid Almansouri

⁷

,

Amber Hassan

⁸

,

Saleh Baeesa

⁹

,

Ahmed K Bamaga

¹⁰

,

Shadi Alkhayyat

¹¹

,

Eyad Faizo

¹²

,

Maher Kurdi

¹

Department of Pathology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia
Department of Surgery, King Abdulaziz University Hospital, Jeddah, Saudi Arabia
Department of Neurosurgery, King Fahad General Hospital, Madinah, Saudi Arabia
Department of Pathology, College of Medicine, Umm Al-Qura University, Mecca, Saudi Arabia
Department of Neurosurgery, King Fahad General Hospital, Jeddah, Saudi Arabia
Department of Clinical Physiology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Department of Laboratory of Translation Neuroscience, CEINGE, Biotecnologie Avanzate, Naples, Italy
Department of Neuroscience, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
Department of Pediatrics, King Abdulaziz University and Hospital, Jeddah, Saudi Arabia
Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Department of Surgery, Faculty of Medicine, University of Tabuk, Tabuk, Saudi Arabia

Folia Neuropathol 2023; 61 (3): 317-325

DOI: https://doi.org/10.5114/fn.2023.131014

Online publish date: 2023/09/06

Article file

- The effect.pdf [0.98 MB]

Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Butt N, Enani M, Alshanqiti M, et al. The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma. Folia Neuropathologica. 2023;61(3):317-325. doi:10.5114/fn.2023.131014.

APA

Butt, N., Enani, M., Alshanqiti, M., Alkhotani, A., Alsinani, T.,  & Karami, M. et al. (2023). The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma. Folia Neuropathologica, 61(3), 317-325. https://doi.org/10.5114/fn.2023.131014

Chicago

Butt, Nadeem, Maryam Enani, Maryam Alshanqiti, Alaa Alkhotani, Taghreed Alsinani, Mohammed Matoog Karami,  and Motaz M Fadul et al. 2023. "The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma". Folia Neuropathologica 61 (3): 317-325. doi:10.5114/fn.2023.131014.

Harvard

Butt, N., Enani, M., Alshanqiti, M., Alkhotani, A., Alsinani, T., Karami, M., Fadul, M., Almansouri, M., Hassan, A., Baeesa, S., Bamaga, A., Alkhayyat, S., Faizo, E.,  and Kurdi, M. (2023). The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma. Folia Neuropathologica, 61(3), pp.317-325. https://doi.org/10.5114/fn.2023.131014

MLA

Butt, Nadeem et al. "The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma." Folia Neuropathologica, vol. 61, no. 3, 2023, pp. 317-325. doi:10.5114/fn.2023.131014.

Vancouver

Butt N, Enani M, Alshanqiti M, Alkhotani A, Alsinani T, Karami M et al. The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma. Folia Neuropathologica. 2023;61(3):317-325. doi:10.5114/fn.2023.131014.

PlumX metrics:

1. Castro F, Cardoso AP, Goncalves RM, Serre K, Oliveira MJ. Interferon-gamma at the crossroads of tumor immune surveillance or evasion. Front Immunol 2018; 9: 847.

2. Castro M, Sipos B, Pieper M, Biskup S. Major histocompatibility complex [MHC1] loss among patients with glioblastoma. JCOC 2020; 38.

3. Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature 2017; 541: 321-330.

4. Chen Z, Hambardzumyan D. Immune microenvironment in glioblastoma subtypes. Front Immunol 2018; 9: 1004.

5. Feng L, Qian H, Yu X, Liu K, Xiao T, Zhang C, Kuang M, Cheng S, Li X, Wan J, Zhang K. Heterogeneity of tumorinfiltrating lymphocytes ascribed to local immune status rather than neoantigens by multi-omics analysis of glioblastoma multiforme. Sci Rep 2017; 7: 6968.

6. Gerloni M, Zanetti M. CD4 T cells in tumor immunity. Springer Semin Immunopathol 2005; 27: 37-48.

7. Han S, Zhang C, Li Q, Dong J, Liu Y, Huang Y, Jiang T, Wu A. Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma. Br J Cancer 2014; 110: 2560-2568.

8. Kilian M, Sheinin R, Tan CL, Friedrich M, Krämer C, Kaminitz A, Sanghvi K, Lindner K, Chih YC, Cichon F, Richter B, Jung S, Jähne K, Ratliff M, Prins RM, Etminan N, von Deimling A, Wick W, Madi A, Bunse L, Platten M. MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors. Cancer Cell 2023; 41: 235-251.e9.

9. Kmiecik J, Poli A, Brons NH, Waha A, Eide GE, Enger PØ, Zimmer J, Chekenya M. Elevated CD3+ and CD8+ tumorinfiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level. J Neuroimmunol 2013; 264: 71-83.

10. Kurdi M, Alghamdi B, Butt NS, Baeesa S. The relationship between CD204 M2-polarized tumour-associated macrophages [TAMs], tumour-infiltrating lymphocytes [TILs], and microglial activation in glioblastoma microenvironment: a novel immune checkpoint receptor target. Discov Oncol 2021; 25: 28.

11. Largeot A, Pagano G, Gonder S, Moussay E, Paggetti J. The B-side of cancer immunity: The underrated tune. Cells 2019: 8: 449.

12. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021; 23: 1231-1251.

13. Nazemalhosseini-Mojarad E, Mohammadpour S, Torshizi Esafahani A, Gharib E, Larki P, Moradi A, Porhoseingholi MA, Asadzade Aghdaei H, Kuppen PJK, Reza Zali M. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features. J Cell Physiol 2019; 234: 4768-4777.

14. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005; 308: 1314-1318.

15. Parajuli P, Mittal S. Role of IL-17 in glioma progression. J Spine Neurosurg 2013; Suppl 1: S1-004.

16. Philip M, Fairchild L, Sun L, Horste EL, Camara S, Shakiba M, Scott AC, Viale A, Lauer P, Merghoub T, Hellmann MD, Wolchok JD, Leslie CS, Schietinger A. Chromatin states define tumour-specific T cell dysfunction and reprogramming. Nature 2017; 545: 452-456.

17. Philip M, Schietinger A. CD8+ T cell differentiation and dysfunction in cancer. Nat Rev Immunol 2022; 22: 209-223.

18. Quezada SA, Peggs KS, Simpson TR, Allison JP. Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol Rev 2011; 241: 104-118.

19. Quail DF, Joyce JA. The microenvironmental landscape of brain tumors. Cancer Cell 2017; 31: 326‐341.

20. Lam H, McNeil LK, Starobinets H, DeVault VL, Cohen RB, Twardowski P, Johnson ML, Gillison ML, Stein MN, Vaishampayan UN, DeCillis AP, Foti JJ, Vemulapalli V, Tjon E, Ferber K, DeOliveira DB, Broom W, Agnihotri P, Jaffee EM, Wong KK, Drake CG, Carroll PM, Davis TA, Flechtner JB. An empirical antigen selection method identifies neoantigens that either elicit broad antitumor T-cell responses or drive tumor growth. Cancer Discov 2021; 11: 696-713.

21. St Paul M, Ohashi PS. The roles of CD8+ T cell subsets in antitumor immunity. Trends Cell Biol 2020; 30: 695-704.

22. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant TMZ for glioblastoma. N Engl J Med 2005; 352: 987-996.

23. Liu S, Yang Z, Li G, Li C, Luo Y, Gong Q, Wu X, Li T, Zhang Z, Xing B, Xu X, Lu X. Multi-omics analysis of primary cell culture models reveals genetic and epigenetic basis of intratumoral phenotypic diversity. Genomics Proteomics Bioinformatics 2019; 17: 576-589.

24. Thommen DS, Schumacher TN. T cell dysfunction in cancer. Cancer Cell 2018; 33: 547-562.

25. Weiss T, Weller M, Roth P. Immunotherapy for glioblastoma: concepts and challenges. Curr Opin Neurol 2015; 28: 639-646.

26. Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 2015; 15: 486-499.

27. Zhang D, Qiu B, Wang Y, Guan Y, Zhang L, Wu A. Temozolomide increases MHC-I expression via NF-κB signaling in glioma stem cells. Cell Biol Int 2017; 41: 680-690.

Copyright: © 2023 Mossakowski Medical Research Centre Polish Academy of Sciences and the Polish Association of Neuropathologists. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma

Nadeem Butt 1 , Maryam Enani 2 , Maryam Alshanqiti 3 , Alaa Alkhotani 4 , Taghreed Alsinani 5 , Mohammed Matoog Karami 6 , Motaz M Fadul 1 , Majid Almansouri 7 , Amber Hassan 8 , Saleh Baeesa 9 , Ahmed K Bamaga 10 , Shadi Alkhayyat 11 , Eyad Faizo 12 , Maher Kurdi 1